CN104490851A - 依色格南的速释膜剂 - Google Patents
依色格南的速释膜剂 Download PDFInfo
- Publication number
- CN104490851A CN104490851A CN201410855629.4A CN201410855629A CN104490851A CN 104490851 A CN104490851 A CN 104490851A CN 201410855629 A CN201410855629 A CN 201410855629A CN 104490851 A CN104490851 A CN 104490851A
- Authority
- CN
- China
- Prior art keywords
- rapid release
- segenan
- buffer
- release membrane
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010078256 antimicrobial peptide IB-367 Proteins 0.000 title abstract description 6
- GUCYBPFJNGVFEB-XELKFLSISA-N iseganan Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@H](CC=3C=CC=CC=3)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(N1)=O)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)C(C)C)C1=CC=C(O)C=C1 GUCYBPFJNGVFEB-XELKFLSISA-N 0.000 title abstract description 6
- 229950000488 iseganan Drugs 0.000 title abstract description 5
- 239000000945 filler Substances 0.000 claims abstract description 9
- 239000004014 plasticizer Substances 0.000 claims abstract description 9
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims description 61
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 238000002360 preparation method Methods 0.000 claims description 33
- 239000000872 buffer Substances 0.000 claims description 14
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 14
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 13
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 13
- 239000008363 phosphate buffer Substances 0.000 claims description 13
- 239000000811 xylitol Substances 0.000 claims description 13
- 235000010447 xylitol Nutrition 0.000 claims description 13
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 13
- 229960002675 xylitol Drugs 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 10
- 229930195725 Mannitol Natural products 0.000 claims description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 10
- 239000000594 mannitol Substances 0.000 claims description 10
- 235000010355 mannitol Nutrition 0.000 claims description 10
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 10
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 10
- 229920000053 polysorbate 80 Polymers 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 8
- 229940075582 sorbic acid Drugs 0.000 claims description 8
- 235000010199 sorbic acid Nutrition 0.000 claims description 8
- 239000004334 sorbic acid Substances 0.000 claims description 8
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 7
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 208000003265 stomatitis Diseases 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 229940037201 oris Drugs 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 4
- 230000000873 masking effect Effects 0.000 claims description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 2
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 238000011017 operating method Methods 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000008347 soybean phospholipid Substances 0.000 claims description 2
- 230000008733 trauma Effects 0.000 claims description 2
- 210000001215 vagina Anatomy 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 4
- 108700042778 Antimicrobial Peptides Proteins 0.000 abstract 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 description 51
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 241000220223 Fragaria Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 101000730859 Sus scrofa Protegrin-1 Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101001052001 Galleria mellonella Fibroin light chain Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000034493 Mucous membrane disease Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000170793 Phalaris canariensis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- KAFGYXORACVKTE-UEDJBKKJSA-N chembl503567 Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@H](CC=3C=CC=CC=3)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(N1)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)C1=CC=C(O)C=C1 KAFGYXORACVKTE-UEDJBKKJSA-N 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000004678 mucosal integrity Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010032966 protegrin-1 Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410855629.4A CN104490851B (zh) | 2014-12-31 | 2014-12-31 | 依色格南的速释膜剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410855629.4A CN104490851B (zh) | 2014-12-31 | 2014-12-31 | 依色格南的速释膜剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104490851A true CN104490851A (zh) | 2015-04-08 |
CN104490851B CN104490851B (zh) | 2017-05-24 |
Family
ID=52932368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410855629.4A Active CN104490851B (zh) | 2014-12-31 | 2014-12-31 | 依色格南的速释膜剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104490851B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288586A (zh) * | 2015-08-28 | 2016-02-03 | 广东海纳川生物科技股份有限公司 | 一种抗菌肽菌丝霉素成膜剂及其制备方法与应用 |
CN108324724A (zh) * | 2018-04-10 | 2018-07-27 | 苏州芝宇生物科技有限公司 | 一种克立硼罗可溶性膜制剂的制法及其应用 |
CN108815141A (zh) * | 2018-08-24 | 2018-11-16 | 中国农业科学院饲料研究所 | 抗菌肽膜剂及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524577A (zh) * | 2003-02-27 | 2004-09-01 | 珠海亿胜生物制药有限公司 | 碱性成纤维细胞生长因子膜剂及其制备方法 |
CN1899600A (zh) * | 2005-07-22 | 2007-01-24 | 上海高科联合生物技术研发有限公司 | 抗菌肽喷雾成膜剂及其制备方法 |
CN1931148A (zh) * | 2006-09-28 | 2007-03-21 | 上海大学 | 乳酸左旋氧氟沙星口腔贴膜的制备方法 |
-
2014
- 2014-12-31 CN CN201410855629.4A patent/CN104490851B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524577A (zh) * | 2003-02-27 | 2004-09-01 | 珠海亿胜生物制药有限公司 | 碱性成纤维细胞生长因子膜剂及其制备方法 |
CN1899600A (zh) * | 2005-07-22 | 2007-01-24 | 上海高科联合生物技术研发有限公司 | 抗菌肽喷雾成膜剂及其制备方法 |
CN1931148A (zh) * | 2006-09-28 | 2007-03-21 | 上海大学 | 乳酸左旋氧氟沙星口腔贴膜的制备方法 |
Non-Patent Citations (1)
Title |
---|
J PETER DONNELLY,ET AL: "Antimicrobial therapy to prevent or treat oral mucositis", 《THE LANCET INFECTIOUS DISEASES》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288586A (zh) * | 2015-08-28 | 2016-02-03 | 广东海纳川生物科技股份有限公司 | 一种抗菌肽菌丝霉素成膜剂及其制备方法与应用 |
CN108324724A (zh) * | 2018-04-10 | 2018-07-27 | 苏州芝宇生物科技有限公司 | 一种克立硼罗可溶性膜制剂的制法及其应用 |
CN108815141A (zh) * | 2018-08-24 | 2018-11-16 | 中国农业科学院饲料研究所 | 抗菌肽膜剂及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104490851B (zh) | 2017-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69930964T2 (de) | Zusammensetzungen und verfahren für mukosale abgabe | |
AU2007298814B2 (en) | Galenic form for the trans-mucosal delivery of active ingredients | |
KR101792200B1 (ko) | 열감응성 겔 마취제 조성물 | |
JP5595683B2 (ja) | イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤 | |
US11376262B2 (en) | Method of treating an inflammatory or infectious disease | |
KR20060123086A (ko) | 콘택트렌즈용 안과용 조성물 | |
DE102008023345B4 (de) | Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung | |
KR20110050511A (ko) | 점막접착성 조성물 및 그 용도 | |
TWI495469B (zh) | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 | |
EP3178469A2 (en) | Vaginal composition for the treatment of urogenital infections | |
CN108210689A (zh) | 一种含有透明质酸的口腔溃疡膜剂及其制备方法 | |
CN104490851A (zh) | 依色格南的速释膜剂 | |
RU2366450C1 (ru) | Средство для лечения тяжелых инфекционных заболеваний и смешанных инфекций | |
CN109464428A (zh) | 一种含有萜烯的经皮渗透贴剂及其制备方法 | |
KR101642537B1 (ko) | 푸시드산나트륨을 사용하고 생체중합체를 혼입한 약용 푸시드산 크림 및 이의 제조 방법 | |
JP2006316009A (ja) | 口腔内貼付剤及びその製造方法 | |
EP3501507B1 (en) | Macrogols for application to the mucosa, and therapeutic uses thereof | |
CN100396290C (zh) | 妇科外用抗菌泡沫剂 | |
KR102111094B1 (ko) | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 | |
KR20160096376A (ko) | 히알루론산, 미네랄 오일 및 계면활성제를 포함하는 안과용 조성물 | |
JP4630931B2 (ja) | 消化管溶性剤型 | |
JP2024504873A (ja) | バイオフィルムの分解又はバイオフィルム形成の予防に使用する組成物 | |
CN104306356A (zh) | 依色格南的缓释膜剂 | |
EP4034083A1 (en) | Lactic acid vaginal film and it's process | |
JP5019923B2 (ja) | プラノプロフェン含有医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240705 Address after: 556000, 4th Floor, Building 3, Mei'e Standard Factory, Luoguan Economic Development Zone, Guandong Town, Congjiang County, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou Province Patentee after: Congjiang Fu Lin Yao Bath Development Co.,Ltd. Country or region after: China Address before: 610041 Fifth Floor 501, B3 Floor, Tianfu Life Science and Technology Park, 88 South Road, Fengjiawan Industrial Park, Chengdu High-tech Zone, Sichuan Province Patentee before: CHENGDU SCISYN PHARMACEUTICAL CO.,LTD. Country or region before: China |
|
TR01 | Transfer of patent right |